Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients
Pediatric Blood & Cancer,

Yancey A et al. – Gender and cumulative dose are important clinical biomarkers of cisplatin ototoxicity. Severity of ototoxicity may be inversely related to age at time of exposure, with very young patients exhibiting higher grades of hearing loss following cisplatin therapy.

Methods
  • The authors performed a retrospective chart review of 102 pediatric patients who had completed cisplatin therapy for osteosarcoma, neuroblastoma, hepatoblastoma, or germ cell tumor.
  • Patients were diagnosed at Riley Hospital for Children between January 1995 and June 2008, were less than 18 years old at diagnosis, and had normal hearing prior to therapy.
  • Audiograms were scored using the Brock scale (0–4), a validated grading system for cisplatin-related hearing loss.

Results
  • Forty-two percent of the patients experienced hearing loss and 28% had moderate to severe ototoxicity (Brock score ≥2).
  • Males were at significantly greater risk for developing hearing loss than were females (P = 0.005, OR 4.812).
  • Age at cancer diagnosis was inversely related to severity of ototoxicity.
  • Patients who suffered Brock grade 3 ototoxicity had a mean age of 4.5 years versus 11.5 years and 7.2 years for grades 1 and 2, respectively (P = 0.02).
  • Cumulative cisplatin dose was also identified as a risk factor for development of ototoxicity (P = 0.03).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: A nationwide register-based cohort study in Denmark CNS Drugs, June 18, 2014    Clinical Article

2 Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis FOCUS, June 16, 2014    Evidence Based Medicine

3 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

4 Re-evaluating the role of antidepressants in cancer-related depression: A systematic review and meta-analysis General Hospital Psychiatry, June 4, 2014    Evidence Based Medicine

5 Does pharmacological treatment of ADHD in adults enhance parenting performance?: Results of a double-blind randomized trial CNS Drugs, June 12, 2014    Clinical Article

6 Association between C-reactive protein and depression: modulated by gender and mediated by body weight Psychiatry Research, June 19, 2014    Clinical Article

7 A comparison of the effects of hatha yoga and resistance exercise on mental health and well-being in sedentary adults: A pilot study Complementary Therapies in Medicine, June 20, 2014    Clinical Article

8 Attachment anxiety is related to epstein-barr virus latency Brain, Behavior, and Immunity, June 23, 2014    Clinical Article

9 Pretreatment brain states identify likely nonresponse to standard treatments for depression Biological Psychiatry, May 23, 2014    Clinical Article

10 Physical diseases among persons with obsessive compulsive symptoms and disorder: A general population study Social Psychiatry and Psychiatric Epidemiology, June 13, 2014    Clinical Article

11 Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy CNS Spectrums, May 30, 2014    Clinical Article

12 Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

13 A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans American Journal of Psychiatry, June 9, 2014    Clinical Article

14 A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- A meta-analysis of 31 studies Full Text BMC Psychiatry, May 20, 2014    Free full text    Evidence Based Medicine    Clinical Article

15 Predicting autism diagnosis by 7 years of age using parent report of infant social communication skills Journal of Paediatrics and Child Health, June 10, 2014    Clinical Article

16 Risk of myocardial infarction and stroke in bipolar disorder: A systematic review and exploratory meta-analysis Acta Psychiatrica Scandinavica, June 2, 2014    Evidence Based Medicine    Review Article

17 Myofascial pain in war veterans with post-traumatic stress disorder Journal of Musculoskeletal Pain , June 11, 2014    Clinical Article

18 Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial Journal of Affective Disorders, June 9, 2014    Clinical Article

19 Elevated fetal steroidogenic activity in autism Full Text Molecular Psychiatry, June 25, 2014    Free full text    Clinical Article

20 Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder SLEEP, May 7, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close